It’s not often that the Trump administration and the anti-poverty NGO Oxfam find themselves singing from the same hymn sheet. (Of course, both have suffered reputational harm from sex scandals.) But they’ve found themselves making the same big-picture point recently: medicines are too expensive. And a key part of the problem is the lack of consistent information about drug pricing.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,